A study published in the Journal of the American Medical Association covering 2014–2024 found that inhalers approved for asthma and chronic obstructive pulmonary disease generated an estimated 24.9 million metric tons of carbon dioxide-equivalent emissions in the United States from 2014 to 2024.
December 31, 2024
high
temporal
Estimate of greenhouse gas emissions attributable to inhalers in the U.S. over a 2014–2024 period reported in a JAMA study.